Where They Stand: John Jacob – Daily Journal

Posted on October 24, 2020 by Danzig

Why are you seeking election?

Im very concerned about the decline of our culture, of our nation. I think our constitutional freedoms are being stripped away from us. I believe that all life should be preserved, that includes the pre-born, specifically. There is a bill that would end abortion in Indiana, and that is a bill that I would co-author and support.

What qualifications and experience make you a good fit for this position?

I actually worked for the Indiana State Board of Accounts, and its a government watchdog group. We audited every level of government in the state of Indiana, except for the federal government. Working with them, I was a sworn officer of the court, and I led many audits.

I also helped to lead our risk management group. I would say, in a nutshell, that I have a strong expertise in fiscal but also law. Being an auditor, I had to be.

What would be your top three priorities if elected?

No. 1 would be to co-author the Protection at Conception Bill which would end abortion in Indiana. Secondly, it would be also to co-author the constitutional carry bill, and push for both of those bills. Three would probably be the issue of our freedoms and our liberties. I dont think that would be a singular issue, and I think there can be multiple issues addressed as it relates to our freedoms and liberties that are being taken away from us.

What are some of the biggest issues facing Indiana today?

Again, I would say abortion.

The issue of our constitutional liberties being stripped from us.

How do you plan to push legislation that addresses your priorities?

I would probably do it the same way a lot of other legislators do it. No. 1 is to author a bill that would be viable, that would be within the boundaries of the Constitution. No. 2, it would be trying to garner support from other legislators, and a lot of that is done by discussion with other legislators.

How do you plan to help your district specifically, and communicate with constituents about what is going on at the Statehouse?

Specifically via mail and emails to communicate whats going on, as far as the pulse of whats going on at the Statehouse. Also, going door-to-door Thats a big reason why I won the primary, because I communicated clearly what I was running on to the voters of District 93. One of the things voters specifically said to me over and over was, I was very pleased that you were very clear about where you stood with issues, and there was no lack of clarity on where you stood. That was something that was very refreshing to them.

What are your thoughts on Indianas COVID-19 response, and what role do you think the General Assembly should play next year when considering pandemic-related legislation?

Definitely the legislature is the one that should be passing legislation as it relates to COVID. That is something that would be up for discussion as far as what would be best for the citizens of Indiana. I would say specifically that it should be in line with the Constitution. Im not dismissing COVID, I want to be clear. I dont want people to think I think COVID is not a reality, that I dont think there are people who are getting sick from COVID and dying. However, with that, there has to be a way to deal with that but yet not violate peoples constitutional rights. (The) executive branch doesnt make law. The legislative branch is the one that makes law.

What is your position on public school funding? How should Indiana address the way it funds schools?

I would go back to the individual because this is talking about children. With children, parents should have the right to be able to direct the education of their children Addressing the freedom that parents have to address the education of their children is first and foremost. Then from there, we can address the issue of where funding goes.

Do you think it is beneficial or detrimental to decision-making that both chambers in the General Assembly have supermajorities?

I would say this, the voters are the ones who vote people into office We vote people into office that we believe are going to best represent our views. Whether I would agree or disagree, because I mean, the tides could turn because if it was a Democrat supermajority, obviously the Republicans wouldnt like that and vice versa I think it would violate our entire system to say, OK were just going to keep everything even as far as whos in. Wed actually have to start removing people from office to balance out the Democrats and Republicans.

Theres always discussion, and the Democrats are able to discuss their views. And if their views are reasonable and legitimate, those are things the other side would definitely listen to. When it comes to issues, whether I agree or disagree with somebody, I want to be able to at least listen to them.

The Jacob File

Name: John Jacob

Party: Republican

Residence: Perry Township

Family: Wife, Angie; six adult children

Occupation: Small business owner

Education: Roncalli High School; IUPUI

Political experience: None

Memberships: LifePoint Church

Read the original post:

Where They Stand: John Jacob - Daily Journal

Last Week in Slovenia: 16-22 October, 2020 – Total Slovenia News

Posted on October 24, 2020 by Danzig

What follows is a weekly review of events involving Slovenia, as prepared by the STA.

If youd like to keep up on the daily headlines then follow those here, or get all our stories in your feed on Facebook.

FRIDAY, 16 OctoberROME/TRIESTE, Italy - National Assembly Speaker Igor Zori held talks with the presidents of both chambers of the Italian parliament, the chairs of several parliamentary commissions and a Foreign Ministry state secretary. The focus of the talks was on reform of Italian electoral legislation. This was also the main topic of what was first official visit of Foreign Minister Ane Logar to the Slovenian community in Italy.BRUSSELS, Belgium - PM Janez Jana said that fake news in the sense of denial of the danger of the new coronavirus, spreading in Europe mainly through social media and in Slovenia also through mainstream media, was what was forcing Europe and individual countries to take harsher measures than would otherwise be needed.BRUSSELS, Belgium - Putting 38% of Slovenian territory under Natura 2000 protection was "a shot in the knee", PM Janez Jana told the press after an EU summit that had climate goals as one of the items on the agenda. He said that the European average for the area, where it is forbidden to produce energy from natural and sustainable sources, is 18%.BRUSSELS, Belgium - The European Federation of Journalists (EFJ) said "appalled by Slovenian Prime Minister Janez Jana's latest attack against the Slovene public broadcaster STA". This comes after Jana's Twitter post on Thursday calling the STA a "national disgrace". "This demonising of public service media and journalism must stop," said the EFJ.LJUBLJANA - Almost 900 new coronavirus were confirmed, a new daily high. The figures come to a positivity rate of roughly 16%.LJUBLJANA - The Infrastructure Ministry defended the national energy and climate plans in the face of a review from the European Commission, saying that in some areas Slovenia's goals were even more ambitious than the bloc's commitments. The ministry also said the Commission highlighted some positive aspects of the plans adopted last February.LJUBLJANA - The Fiscal Council warned that the budget expenditure planned for the next two years is too high, while also saying that the divergence from the fiscal rule was understandable and could be allowed, considering the coronavirus pandemic.LJUBLJANA - Anti-government protesters returned to bicycle protests yesterday. Police said a few hundred gathered and 33 violations of the ban on gatherings in public were recorded.TORONTO, Canada/GRAZ, Austria - Magna International, the Canadian-Austrian automotive multinational, announced it would start producing Fisker Ocean, an electric SUV, in 2022. According to unofficial reports by the Austrian Kleine Zeitung, the car would be assembled in Magna's plants in Graz, Austria, and in Hoe, near Maribor.LJUBLJANA - The second Slovenia-wide digital radio network, a technology known by its acronym DAB+, was launched. The new multiplex carries the signals of regional and local radio stations, and stations serving the Italian and Hungarian minorities.LJUBLJANA/SLOVENJ GRADEC - The Association of Journalists and Commentators expressed concern over "a renewed abuse of the wheels of the judiciary" after Bojan Poar, author and proprietor of the news portal Poareport, received a suspended three-month prison sentence for defamation and insult due to an article in which he alleged that Maribor Mayor Saa Arsenovi and his former aide Matja tandeker had bribed bankers.

SATURDAY, 17 OctoberLJUBLJANA - Slovenia has condemned a terrorist attack in a Paris suburb in which an assailant beheaded a teacher. "We need to enforce zero tolerance for terrorism and street violence across #EU," Prime Minister Janez Jana said on Twitter.LJUBLJANA - The share of coronavirus tests that came back positive exceeded 19% for the first time on Saturday, as 726 cases were confirmed in 3,765 tests.LJUBLJANA - The Association of Journalists and Commentators (ZNP) condemned an incident that occurred during a 16 October protest in Ljubljana and involved the rapper Zlatko grabbing the camera from a Nova24 cameraman. It said this was an "attack on journalistic freedom and consequently on freedom of expression." The Slovenian Journalists' Association condemned all forms of violence, both verbal and physical.WROCLAW, Poland - Slovenian writer Goran Vojnovi was awarded the Angelus Central European Literary Prize, conferred to works by Central European writers translated into the Polish, for his 2013 novel My Yugoslavia. The annual award is conferred by Wroclaw to writers who take up the most important topics for the present day.

SUNDAY, 18 OctoberLJUBLJANA - The government officially declared a coronavirus epidemic for the entire country starting on 19 October. meaning that the national protection and rescue plan was activated. The epidemic was declared for an initial period of 30 days. Prime Minister Janez Jana called for responsibility and solidarity in the face of the pandemic in a video address to Slovenian citizens. He said a challenging period of cold weather was ahead, which required effective measures.LJUBLJANA - Slovenia confirmed 537 new coronavirus cases in 2,637 tests. The positivity rate exceeded 20% for the first time. The 14-day cumulative rate of infection per 100,000 people reached 339 compared to 317 the day before.

MONDAY, 19 OctoberLJUBLJANA - President Borut Pahor delivered a video address to the people underlining that at the time of crisis, community closes its ranks. "We have to be courageous and determined but also tolerant and patient. This is particularly important for politics. It must make an honest effort for mutual respect and cooperation," he said.LJUBLJANA - The number of new coronavirus infections reached 794 in 4,326 tests. Two more people died, brining the death toll to 192. About 1% of Slovenia's population is infected with Sars-CoV-2 based on the test positivity rate, the head of the government task force Bojana Beovi said.LJUBLJANA - Facing criticism from the opposition in parliament about the government's response to the Covid-19 epidemic, Prime Minister Janez Jana assured MPs that Slovenia had prepared well for the second wave. He said the second wave of the epidemic would eventually pass and that only then it would be possible to make comparisons with other countries.LJUBLJANA - Prime Minister Janez Jana presented the government's plans regarding the distribution of EU and state recovery funds. He said investments were in the healthcare system and infrastructure, which would include two new infectious disease clinics and nursing hospitals in all regions.LJUBLJANA - Foreign Minister Ane Logar hosted his counterpart from North Macedonia Bujar Osmani for talks that focused on preparations for an intergovernmental conference at which North Macedonia expects to start EU membership talks. Logar expressed the belief that the talks would start during Germany's presidency of the EU.LJUBLJANA - President Borut Pahor stressed at a virtual summit of the Three Seas Initiative that this platform offers a unique opportunity to change this part of Europe into a modern, sustainable and innovative society. He added that the initiative must not be understood as a grouping of certain EU members countering other members. Foreign Minister Ane Logar took part in a ministerial panel devoted to smart money.LJUBLJANA - The Nova Gorica Administrative Court was reported to have annulled the dismissal of former director of the National Bureau of Investigation (NBI) Darko Mueni. The court's decision is final, so there is no possibility of an appeal.LJUBLJANA - Ljubljana's city councillors adopted a statement condemning any activities or gatherings of paramilitary or nationalist groups in the capital. The opposition Democrats (SDS) and New Slovenia (NSi) protested, unsuccessfully proposing that the item be removed from the City Council's agenda.LJUBLJANA - Chief supervisor of telco Telekom Slovenije Ale abeder and supervisors Barbara Cerovek Zupani and Bernarda Babi resigned, citing the current situation in the five-strong supervisory board. abeder expects the remaining two supervisory board members to follow suit.LJUBLJANA - Economy Minister Zdravko Poivalek signed a set of amendments to Slovenia's association agreement with the European Space Agency (ESA), which he said constituted an important step towards full-fledged membership. The minister expects cooperation with ESA to deepen further.TUESDAY, 20 OctoberLJUBLJANA - A temporary 9pm-6am curfew entered into force across Slovenia to limit the spread of coronavirus. The ceiling for gatherings was lowered from ten to six people and a blanket ban on movement among statistical regions put in place, albeit with exceptions related to work, emergency situations and services, family assistance and farm work.LJUBLJANA - A record 1,503 Sars-CoV-2 infections were confirmed as the test positivity rate exceeded 25%. Covid-19 hospitalisations rose by 20 to 333.TALLINN, Estonia - FM Ane Logar met his Estonian counterpart Urmas Reinsalu as he started a three-day tour of the Baltics, with the pair expressing the wish for closer cooperation on the bilateral and EU levels in digital services.LJUBLJANA - The centre-left opposition parties called on the government to mend its ways, which they argue are the reason for what they see as a "fatefully low level" of public trust in measures and recommendations aimed to contain the rapid spread of coronavirus in the country.UDINE, Italy/BILBAO/Spain - Slovenian cyclist Jan Tratnik (Team Bahrain McLaren) won the 16th stage of the Giro d'Italia between Udine and San Daniele del Friuli to become only the fifth Slovenian ever to win a stage at the prestigious road race around Italy, while his more celebrated compatriot Primo Rogli (Team Jumbo-Visma) won the first stage of the Vuelta a Espana.

WEDNESDAY, 21 OctoberLJUBLJANA - Slovenia's coronavirus tally soared to another daily record as 1,663 infections were confirmed from a record 6,215 tests, a positivity rate of over 25%. Hospitalisations increased to 357, with 62 patients in intensive care.LJUBLJANA - Ane Erbenik ended up two votes short of appointment as Constitutional Court judge in a 44:35 secret ballot at the National Assembly. The result was the same for the nominee for Banka Slovenije vice-governor Arjana Brezigar Masten, who also needed the absolute majority of all votes. The coalition said this was not an indication of disunity in its ranks.LJUBLJANA - MPs passed changes to the integrity and prevention of corruption act which the government argues strengthen the preventive and supervisory role of the anti-graft commission. They also aim at clearly delineating the powers in prosecution of corruption between the commission on the one hand and the police and prosecution on the other.RIGA, Latvia - Foreign Minister Ane Logar continued his three-day tour of the Baltics by meeting his Latvian counterpart Edgars Rinkevis for talks that focused on the importance of coordinating measures to battle the Covid-19 pandemic. They called for a joint EU approach in coordinating these measures but noted that this was largely within the purview of national governments.VILNIUS, Lithuania - Foreign Minister Ane Logar met Belarusian opposition leader Svetlana Tikhanovskaya as part of his visit to Lithuania. He said that Slovenia advocated dialogue between all political stakeholders, called for peaceful talks, and expressed support for the efforts made as part of the Organisation for Security and Co-operation (OSCE) and Council of Europe.LJUBLJANA - The National Assembly unanimously passed amendments to the environmental protection act designed to tackle the long-running problem of packaging waste and to transpose EU directives in the field. Under the amendments, packaging waste treatment companies will need to accept all waste from waste collection utility companies based on a fee paid by the companies that produce such waste.LJUBLJANA - The National Assembly endorsed an amendment to the motorway tolling act that creates the legal basis for the e-tolling of cars. The new system is to become operational by the end of next year and drivers will be able to buy "electronic vignettes" via an app, online or at service stations.

THURSDAY, 22 OctoberLJUBLJANA - Slovenia will put in place new restrictions to limit the spread of coronavirus. Non-essential shops will be closed, as will hotels, kindergartens and student dormitories, Prime Minister Janez Jana announced. The measures, entering into force on Saturday, will initially be in place for a week and will then be re-evaluated.LJUBLJANA - The government asked parliament to activate Article 37a the defence act which gives members of the Slovenian Armed forces certain police powers on the border. The proposal, which the government says is primarily needed because of the additional burdened placed on police by the epidemic, needs a two-thirds majority.LJUBLJANA - Prime Minister Janez Jana spoke via videoconference with German Chancellor Angela Merkel. They discussed the Covid-19 situation in Europe, the EU presidency trio's activities and the situation in the Western Balkans. Jana said that Germany had offered emergency medical equipment should Slovenia require it.VILNIUS, Lithuania - Foreign Minister Ane Logar wrapped up a three-day tour of the Baltics by meeting Lithuanian Foreign Minister Linas Antanas Linkeviius. Cooperation between the countries at bilateral, European and multi-lateral levels being on the agenda, in addition to the situation in Belarus.LJUBLJANA - Defence Minister Matej Tonin had an informal videoconference with his German and Portuguese counterparts, Annegret Kramp-Karrenbauer and Joao Gomes Cravinho. The talks focused on European defence policy.LJUBLJANA - Singer-songwriter, musician and poet Vlado Kreslin is the recipient of this year's Jeek Award, an accolade celebrating creative and witty radio and television oeuvres and achievements. Kreslin is instilling a spirit of freedom, solidarity, tolerance and joie de vivre in Slovenia's cultural sphere, the judging panel has said.

");$("#middle-position-inner").detach().appendTo('#middle-position');});})(jQuery);

Last Week in Slovenia: 16-22 October, 2020 - Total Slovenia News

Taxpayer Tricks and Treats for Halloween 2020 – Business Wire

Posted on October 24, 2020 by Danzig

WASHINGTON--(BUSINESS WIRE)--As if 2020 wasnt scary enough, today Citizens Against Government Waste (CAGW) released its 20th annual compilation of hair-raising, harrowing, and horrifying Taxpayer Tricks and Treats:

Trick: The House Robs Taxpayers of $3 Trillion

In an attempt to shake down taxpayers and steal their money in the dead of night, the House of Representatives approved the $3 trillion HEROES Act on May 15, 2020, with a $915 billion bailout of state and local governments. But according to an August 24, 2020 Department of the Treasury report, of the $150 billion provided to the states under the CARES Act, 37 states have spent less than 25 percent of their allocated funding, and 23 of those states have spent less than 10 percent. After howls of protest from taxpayer groups like CAGW and taxpayers in states that had not wasted money before the pandemic, the Senate rejected both the first version of the HEROES Act and a second version that cut the bailout to $436 billion. But taxpayers can expect the bailout to be resurrected if the Democrats control Congress and the White House after the November 3 elections.

Treat: Cutting Red Tape is Helping the U.S. Recover from Coronavirus

As a breath of fresh air in the rank atmosphere of partisanship that has permeated the nation for much of 2020, more than 850 rules and regulations have been terminated, suspended, or amended at every level of government to help the country recover from COVID-19. It would be a great treat for taxpayers to see the full implementation of President Trumps May 19 Executive Order that directs federal agencies to review regulations that were suspended, modified, or waived to determine if these changes should be made permanent.

Trick: The Socialist Apocalypse Is as Frightening as Ever

Socialist policies keep rising from the dead. Behind almost every terrifying corner, toxic programs are being peddled to vastly expand the scope and power of the federal government while threatening individual freedom and liberty. An estimated 220 million Americans would frightfully lose their private insurance plans under Medicare for All. The Green New Deal, which aims to overhaul nearly every sector of the economy, could cost a petrifying $93 trillion and destroy the economy. Everyone should fear spooky ideas like free public college that would cost $47 billion annually, forgiveness of student loans that would cost $2.2 trillion over 10 years, and free childcare that would cost $70 billion annually. Taxpayers should make sure their elected officials run far, far away from the Socialist Grim Reaper.

Treat: Broadband Resiliency Has Been Divine During the Pandemic

As millions of Americans have made the shift to telework, online education, and telehealth during the scary pandemic crisis, broadband internet service providers in the U.S. have managed network traffic extremely well (unlike many European countries), proving that private sector investments in broadband are working. The Federal Communications Commission (FCC) initiated the Keep Americans Connected program, with widespread financial commitments from private sector providers, to ensure that Americans do not lose telephone and broadband. The FCC also provided temporary licenses in the 5.9 GHz spectrum band to several providers to allow them to use this spectrum to connect more homes across the country.

Trick: The National Debt Will Haunt the U.S. Forever

The current national debt of $27 trillion is set to grow at an alarming record pace over the next decade. A January 2020 Congressional Budget Office (CBO) report forecast an average annual deficit of $1.3 trillion between fiscal years (FY) 2021 and 2030, rising to $1.7 trillion by the end of the decade, adding a horrifying $13 trillion to the national debt and bringing it to $39.8 trillion.

While the January estimates were eerie enough, the October CBO budget review reported that the FY 2020 deficit was $3.1 trillion, more than three times the FY 2019 deficit, and 15.2 percent of gross domestic product (GDP). This would be the largest deficit relative to the economy since 1945. In its September 2020 long term outlook report, CBO estimated the FY 2020 deficit would be $3.3 trillion and the national debt would grow to a shocking (and unsustainable) 189 percent of GDP by 2049, which is 45 percentage points higher than the estimate made in 2019. The numbers are mind numbing, and the consequences are frightening, unless something is done to prevent this financial plague.

Treat: Increased Mid-Band Spectrum for 5G Networks Is a Reality

As part of its 5G-FAST plan, the FCC has increased the amount of mid-band spectrum available for 5G deployment, a sweet gift to taxpayers that is as good as any Halloween candy. While the pandemic delayed some deployment of 5G both in the U.S. and around the world, the FCC still completed the millimeter wave spectrum band auction, which is critical to implementing 5G deployment in urban and more densely situated markets, netting $4.47 billion in revenue for taxpayers. The c-band spectrum auction, slated to begin on December 8, 2020, which provides a critical 280 MHz of mid-band spectrum for 5G deployment across the country, will add more revenue to the Treasury, and keep the U.S. ahead of wicked competitors like China in the race to 5G.

Trick: Importation of a Witches Brew of Canadian Drugs

Double, double, toil and trouble, fire burn, and cauldron bubble. Just as Macbeths dangerous and wicked weird sisters could predict and influence the future, drug counterfeiters are plotting right now how to take advantage of the Trump administrations regulation to allow states to import drugs from Canada. But Canadian officials have repeatedly said they will not export their drugs to U.S patients, since the country already experiences drug shortages for its own citizens. And the policy prevents certain drugs from being reimported into the U.S. like biologics, which are among the most expensive. Even if drugs are imported, the cost of compliance with strict federal safety requirements will likely negate any savings. Ghastly, greedy counterfeiting creatures will be emboldened to cook up dangerous concoctions that may contain worse ingredients than a fillet of fenny snake, eye of newt, or toe of frog. Theyll do anything to sell their deadly witches brew to unsuspecting American citizens, from designing fake Canadian websites to selling their ghoulish wares on the street.

Treat: States have Sweet Success with Occupational Licensing Reform

Many states have had sweet success with occupational licensing reform during the coronavirus pandemic, including recognition of out-of-state medical licenses for telehealth and reduced educational requirements for various professions. Many states have already made permanent changes and others are considering such action. Florida, which ranked fifth according to the Institute for Justice for the most bloodcurdling and burdensome laws in the nation, permanently changed occupational licensing laws for hairdressers, interior designers, nutritionists, and workers in other fields. Arizona, Iowa, Idaho, Missouri, and Utah have also enacted universal occupational licensing reform, which will make it easier for their citizens to find work as the economy recovers from the pandemic.

Trick: Most Favored Nation Zombie Price Controls

One way to turn Americas vibrant biopharmaceutical research and development into a zombie apocalypse would be the permanent adoption of President Trumps most favored nation (MFN) Executive Order drug pricing policy for Medicare. MFN adopts price controls, which never work, by allowing Medicare to pay the lowest price for a drug found in a select group of mostly European countries. In the late 1980s, the European drug industry spent 24 percent more than the U.S. on pharmaceutical research. But socialist healthcare systems turned the European pharmaceutical industry into the walking dead of research and development by 2004, when it trailed the U.S by 15 percent. In a not too distant future, after the U.S. biopharmaceutical industry has been bitten by MFN, it too will become a zombie, virtually unresponsive to finding cures for complex diseases like Alzheimers, Lou Gehrigs disease (ALS), and muscular dystrophy. In the middle of a pandemic, the U.S. has picked a bad time to give up global leadership in pharmaceutical R&D.

Treat: Candy Corn Is Sweet, but Cocktails Are Sweeter

The pandemic lockdowns have haunted the liquor industry, but several states have proposed novel ideas to alleviate the serious economic impact by either temporarily or permanently allowing restaurants and liquor stores to offer yummy to-go cocktails. These states include Colorado, Delaware, Iowa, Massachusetts, Michigan, Missouri, and New Jersey. In Ohio, Governor Mike DeWine signed HB 699 into law on June 10, 2020, to permanently allow the sale of alcoholic beverages by carryout or delivery. The Buckeye Institute noted that the hospitality and leisure industry had nearly 142,700 fewer jobs compared to 2019. Allowing carryout and delivery for alcoholic beverages will be a sweet treat for these workers and consumers.

Trick: Maryland is Haunted by Spooky Taxes

Lawmakers in Maryland summoned something wicked when they proposed spiking the states sale tax on alcohol from 9 percent to 10 percent in 2021. House of Delegates Minority Leader Nic Kipke (R-Pasadena), predicted, This type of tax increase could be the final straw that puts many out of business. The measure is expected to raise an estimated $14 million a year from Maryland taxpayers within the first two years after the law would be enacted and will continue to haunt them with an additional $22 million each subsequent year. Like other sin tax increases, those figures will be shockingly short of expectations, as millions of Marylanders can walk, bike, scooter, or drive themselves to D.C., Virginia, Delaware, Pennsylvania, and West Virginia, as well as go online to buy alcohol.

Trick: AB 5 Haunts Gig Economy Workers

An attempt by California Assemblyman Kevin Kiley (R-Rocklin) to reverse provisions of AB 5, a scary law that has haunted California gig economy workers for the past year fell to its grave. But voters still have a chance to undo the laws application to Uber and Lyft drivers if Proposition 22 is approved on the November 3 ballot. The supposed purpose of AB 5 was to protect workers by guaranteeing a minimum wage, sick leave, workers compensation, and unemployment benefits. Instead, the law has led to the loss of work for millions of independent contractors in every imaginable industry. In what could be the death knell for app-based workers and other self-employed and self-sufficient Americans across the country, former Vice President Joe Biden plans to federalize the law if he is elected President on November 3.

Trick: The Fiscal Nightmare Continues at the Department of Defense

The 19-year procurement nightmare known as the F-35 Joint Strike Fighter (JSF) program is approximately $195 billion over budget and nine years behind schedule. The total costs for the F-35 are estimated to reach $1.727 trillion over the lifetime of the program, which is just an evil expenditure of the taxpayers money. Of this total, $1.266 trillion will be needed for operations and support. Of course, the programs many ghastly problems have not stopped the Department of Defense (DOD) from asking for funding, and members of Congress from supplying it, oftentimes exceeding the budget request. This trend continued in FY 2020, when legislators added $2.1 billion to fund the acquisition of 22 JSFs beyond the amount requested by the Pentagon. Since FY 2001, members of Congress have added 29 gruesome earmarks for the JSF program, costing $8.9 billion.

Treat: DODs Chief Management Officer Makes Progress (May Be a 2021 Trick)

In an effort to get the Pentagons hideous business operations in order, the Chief Management Officer (CMO) position was created in fiscal year 2017. The position has already proved its worth, identifying vast sums spent to stock a commissary system with items that are of limited interest to customers. Of the 1.4 million items carried, nearly 1 million produce less than $1,000 in revenue each year, including 23 brands of apple juice. Overall, the CMO has claimed to have identified $22.3 billion in savings between FYs 2018 and 2021. Taming the bureaucratic beast has always been and will continue to be a challenge because of institutional inertia, contractor resistance, and the Pentagons benefactors in Congress. In fact, just three years after touting its creation and despite its success, legislators have taken steps to unwind the CMO position. Instead of allowing some of the Pentagons most horrible management practices to be resurrected, Congress should support efforts to strengthen and institutionalize the office.

Trick: DOD Still Fails to Complete a Clean Audit

The DOD scarily remains the sole federal agency to have never undergone a clean audit. The books are so unnerving that areas within the DOD have been on the Government Accountability Offices list of programs at high risk for waste, fraud, abuse, and mismanagement since 1995. In November 2018, then-Deputy Secretary of Defense Patrick Shanahan took a stab at describing the Pentagons attempt at an audit, stating, We failed the audit, but we never expected to pass it. The DOD did not indicate how much money turned up missing in the audit, but with a budget topping $800 billion when factoring in the $70.7 billion provided in the Overseas Contingency Operations account, that amount is likely to be shocking to taxpayers.

CAGW is the nations largest nonpartisan, nonprofit organization dedicated to eliminating waste, fraud, abuse, and mismanagement in government.

See the original post here:

Taxpayer Tricks and Treats for Halloween 2020 - Business Wire

Letters to the editor – News – The Hutchinson News

Posted on October 24, 2020 by Danzig

We trust Jason

We are in support of Jason Probst for the 102nd House District. We belong to a motorcycle rights organization, and every year we have a motorcycle lobby day at the Capitol. Jason is more than accommodating to speak with us about motorcycling issues and other local issues. He is very open, honest, and loyal. He votes according to what is best for his local constituents. He will listen to what you have to say. Sometimes he might not agree with you, but at least hes honest. There is no fooling around. He will tell you if he does not think something will work, and suggest what we might do instead. Jason truly is a good representative of the 102nd District. We can approach him by email, on Facebook, or even in the local grocery store or at Third Thursday, and he is very approachable. We trust Jason.

Tony and Tammy Railsback

Rural Sterling

Vote Probst

I am a retired school teacher. I know Jason Probst from some work we did together at Stage 9, one of the local community theatres in Hutchinson. The reason I am supporting Jason in the 102nd House District race is because a vote to re-elect Jason is a vote for yourself. I have never met anybody who cares more about you understanding what the issues are and who will get back with you if you have a question. He is just extraordinary that way. Vote for Jason!

Paula Rothe

Hutchinson

Reliable and honest

I am a moderate Republican who lives out in the Yoder area. I am supporting Jason Probst for re-election to the 102nd House District. I got to know Jason, and I know hes a moderate Democrat. But we have talked and spent some time together. I have found that Jason is very reliable and honest. He is just a good soul. If I was in his district, which I am not, I would vote for him. For those that are in his district, I hope you will vote for him so he can continue to represent our community.

David Ratzlaff

Hutchinson

Vote for small business

I am a small business owner here in Hutchinson, and I am supporting Jason Probst for the 102nd House District. I own a small salon. There have been many times over the last few months that Jason has helped me. With all the uncertainty and chaos involved with COVID from shutting down small businesses and then trying to get them opened back up, Jason pushed out so much information that helped small business owners like me make it through. He has helped me in ways I cannot even begin to describe in a short 150-word letter to the editor. I hope people will make their decision on who to vote for based on the person, and not necessarily based on the political party. Please vote for Jason.

Brandy Sheahan Harris

Hutchinson

Why not Barbara Bollier?

Do Kansans really believe that Barbara Bollier, if elected, will be a Lone Ranger, U. S. Senator and buck the ultra-liberal, Democrat leadership of her party back in D.C.? She claims to be a "moderate," but she did not vote like one when she was a Republican in the Kansas State Senate. She got elected as a Republican, but after voting with the Democrats over 90% of the time, she switched parties, showing her true colors. She is rabidly pro-abortion, and the N.R.A. gives her an "F" rating and if you appreciate POTUS Trump's conservative judicial, court appointments, you will not want to vote for Barbara Bollier. I promise you that she will side with Senator Leader, Chuck Schumer to block those nominees in the effort to make the U.S. judiciary another voting/legislative arm of the Democrat Party, should the Republicans lose the U.S. Senate. Also, no more Amy Coney Barrett-type, U.S. Supreme Court nominees will ever be confirmed if that happens.

As a U. S. House Representative, Roger Marshall has voted with POTUS Trump 98% of the time. If you appreciate the Trump policies, please remember that when you go to cast your ballot.

Carolyn Simms

Republic

Vote pro-life

I am so thankful I live in a country where we have the freedom to make choices when we vote. However, the "unborn" have no choice and no voice. We do know they are fighters and will fight to live. So lets vote for them by voting for pro-life candidates on Nov. 3.

Marilyn Kemple

Lyons

Stroberg for Kansas

When Kansans look around, we see our four surrounding neighbor states have all joined in the 38 states that have now adopted some form of Medicaid Expansion. What does it cost Kansas not to participate? About $800 million to $900 million a year and that equals about 85 percent of the average annual Kansas wheat crop.

Kingman should not be paying an increased local sales tax AND letting our legislators give away the dollars available for keeping our local rural hospital open.

Jeff Stroberg, candidate for the 114th legislative district, is a CPA and former business executive. He understands that Kansas is making a huge financial mistake and an equally huge health care mistake. Nothing could be more obvious during the Covid-19 pandemic.

I'm backing Mr. Stroberg's campaign because he is a logical thinker who will stand up for good government and not be swayed by party politics and he has a lot of experience working with teams to solve business problems.

We need Jeff Stroberg in the Kansas Legislature. Please vote for him Nov. 3.

Pat Maloney

Kingman

Understand and enforce

Reno County's Health Officer Karen Hammersmith was quoted in the Hutchinson News as lamenting that "People don't understand what a huge problem we have".

This is a direct result of Reno County officials failing to provide reasonable details during this crisis. Standing behind privacy concerns, officials do not provide details.

In this case, a lack of details has led to deniers and obstructionists getting the upper hand and the size of the problem getting out of control.

Deniers point out that no one knows anyone positive or can name a person who has died from COVID-19. Without details, it is a hard talking point to overcome.

I understand the need to protect victims and families from zealots who think COVID-19 patients need to be condemned. But reasonable details can be provided, especially now that the numbers are so large. Age range, sex, race/ethnicity, type and location of transmission, identification with a cluster, the presence of risk factors can all be released. This goes for both deaths and infections.

Tell us what the contact tracers and investigators are finding out. Were the victims wearing masks, social distancing, engaging in risky behaviors? Again, generalizations are better than nothing.

A quick note to local media, why are you not pushing and investigating? The dashboard numbers are a good start, but they are not the true story.

And lastly, to the Reno County Commission, it is time to enact smart and reasonable shutdowns and an enforceable mask requirement, and then enforce them.

There 15 dead Reno County residents as of this writing!

Eric Buller

Hutchinson

Vote Paul

My husband and I want to say a few words in support of a long-time friend, and our 104th District Representative, Paul Waggoner.

He is a common-sense conservative and shares our American values and he realizes they are under constant attack. Thats why we 100% support Paul.

He stands up boldly and does not hide his principles. We need someone we can truly trust to be our voice.

He is a fiscal conservative.

He voted to help and improve to keep KPERS solvent.

Wants sensible tax reform.

Voted for the Value Them Both Amendment.

Wants to protect the 1st and 2nd Amendments.

Hes got our vote. We ask you to consider voting for Paul Waggoner. There is so much at stake in this election.

Gary and Linda Witt

Buhler

Go here to see the original:

Letters to the editor - News - The Hutchinson News

Rep. Cynthia Lummis Speaks to Voters in Thermopolis | – mybighornbasin

Posted on October 24, 2020 by Danzig

The event took place at the Hot Springs County Museum and Cultural Center in Thermopolis.

Lummis is currently running to fill the seat soon to be vacated by Senator Mike Enzi, who announced his retirement in May of 2019.

During Wednesdays event, Lummis discussed a variety of topics that included her fiscal conservative values, food origin labeling, land rights, and energy production. She specifically discussed her all of the above energy philosophy that wouldnt rule out carbon capture technology to enhance coals viability.

Lummis also cautioned voters of a massive budget increase should the Democrats to win the White House and Senate, and maintaincontrol over the House of Representatives.

An audience member asked her about the Affordable Care Act and the Republican plan to replace it. She stated that there are plans but Senate Majority Leader Mitch McConnell is not ready to introduce them yet.

While discussing the role of the federal government in mineral and energy regulation, land management rights, and freedom of choice, Lummis said the role of the federal government is to protect our rights and that is what I want to do.

Here is the original post:

Rep. Cynthia Lummis Speaks to Voters in Thermopolis | - mybighornbasin

Parliament body: Freedom Fighters’ monthly honorarium to be raised to Tk20,000 from Tk12,000 – Dhaka Tribune

Posted on October 24, 2020 by Danzig

Step taken to ensure that freedom fighters can lead a solvent life

The monthly honorarium for a freedom fighter is going to be raised to Tk20,000 from Tk12,000 in the current fiscal year as a proposal in this regard has recently been sent to the Finance Ministry.

This information was disclosed at the 14th meeting of the parliamentary standing committee on the Liberation War Affairs Ministry on Sunday.

The honorarium is going to be increased by Tk8,000 so that the freedom fighters can lead a solvent life, said the ministry in the meeting held with parliamentary bodys chairman Shajahan Khan in the chair.

The committee recommended the Bangladesh Muktijoddha Kalyan Trust to provide monthly medical expenses to the freedom fighters as needed instead of the existing system.

The parliamentary watchdog formed a three-member subcommittee to report over the authenticity of different alleged irregularities of the Director General of Muktijoddha Kalyan Trust. The subcommittee was asked to place its report before the main committee within the next two months.

The Committee suggested the placement of an elaborate report about the previous recruitments in its next meeting as well as the formation of a committee to modernize the organogram of the trust.

The meeting also discussed Jatio Muktijoddha Council (Jamuka) and recommended placement of the financial statement of Jamuka in the next meeting of the committee.

Committee members Liberation War Affairs Minister AKM Mozammel Haque and Kazi Firoz Rashid attended the meeting, said a parliament handout.

Continue reading here:

Parliament body: Freedom Fighters' monthly honorarium to be raised to Tk20,000 from Tk12,000 - Dhaka Tribune

Corporate Consultants Set Their Targets on American Universities – The Nation

Posted on October 24, 2020 by Danzig

The New Schools University Center on Fifth Avenue. (Alexi Rosenfeld / Getty Images)

Subscribe now for as little as $2 a month!

Last year, the leadership of The New School (TNS) celebrated its storied progressive history by organizing a centennial festival. The event, featuring artistic events, panels, and exhibitions, was intended to highlight its reputation as a quirky, heterodox university committed to social justice. We ask the questions that lead to new questions, challenging the status quo, said the announcement. The festival was also a hugely expensive event, promoted as a fundraiser, albeit one seemingly quite ineffective at its goal of raising money. Months down the line, the university is struggling with a projected budget shortfall of $130 million. But contrary to the celebratory spirit of its carefully crafted public image, the leadership is attempting to transform the universitywithout the input and against the wishes of faculty, staff, and studentsinto a corporate paragon of anti-labor austerity.Ad Policy

On August 6, employees of The New School received an e-mail from the new president, Dwight A. McBride, a long-time administrator as well as a scholar of race and literary studies. The e-mail announced that the school would undergo extensive reimagining and that it had hired Huron Consulting, a firm with a dedicated practice focused on higher education, to guide them. Many of us in the TNS community were flabbergasted by the decision to invest hundreds of thousands of dollars in an external consulting company in the middle of a purported fiscal crisis, rather than mobilizing resources and expertise already present in-house. Union members were concerned about the possibility for union busting given the new presidents stance on unions.

As it turns out, they were right to be worried. On October 2five months after Huron was hired, and with the approval of the Board of Trusteesthe school laid off 122 employees to offset the projected budget shortfall. More than a third of the laid-off employees were union members, and essential positions were eliminated in student advising, health services, and departmental administration. The total number of employees who have lost their jobs and health insurance in the middle of a pandemic is even higher because dozens of employees furloughed in March will not be recalled.

Taken together, the number of employees laid off to combat administrative bloatthe steady increase in spending on administrative positions, including substantial increase in salaries and related benefits for the leadership of the universityapproximates 20 percent of The New Schools staff. The layoffs made minimal difference to the budget shortfall: In fact, they are only meant to result in annual savings of $12 million, starting from the fiscal year 2022. The decision to throw around 200 workers into unemployment in the midst of the worst pandemic in a century looks all the more cynical and shocking.

Huron, the shadowy entity in dialogue with the administration behind closed doors, is a corporate consulting firm that has been mired in corruption from the beginning. It was established in 2002 by 25 former executives of Arthur Andersen, an accounting agency that went under in 200102. The agency had been cooking the books for the energy giant Enron, a company that became a household name signifying corporate corruption, as well as the subject of a bestselling book and a documentary. Using mark-to-market (MTM) accounting, Enron was able to claim prospective future profits and list them on its current balance sheet, wildly and fraudulently inflating the companys value. This was not its only crime. Enron routinely advocated the privatization of essential services and resources and expanded its operation to India, Mozambique, and Argentina. In India, Human Rights Watch accused the firm of paying police to violently attack protesters. By the time the company collapsed,shareholders had lost $74 billion, and its employees lost billions in pension benefitsall under the watchful eye of Arthur Andersen.

It didnt take long for Huron to follow in the footsteps of its corrupt creators. In 2009, Huron became embroiled in its own scandal, accused of overstating pretax income from 2005 to early 2009. The consulting firm ended up having to pay out millions of dollars, between a civil fine and reparations to shareholders. Perhaps unsurprisingly, several of Hurons executive leaders are Republican Party donors. In spite of the occasional donation to a Democratic candidate, Huron executives seem to be particularly keen on supporting Republicans like John McCain, Mike Pence, Mitt Romney, George W. Bush, and Ted Cruz.

Huron turned its eye to the field of higher educationin 2015. Remarkably, Hurons own primers point to postHurricane Katrina dispossession as a model for universities looking to navigate the crises brought about by Covid-19. In a report titled COVID-19 and Hurricane Katrina: Parallels and Lessons Learned, Huron advocates that universities immediately institute aggressive measures such as staff and faculty layoffs, program closures, salary reductions, and hiring freezes. The fact that renewal plans engineered by private and public entities in the aftermath of Hurricane Katrina exacerbated racialized dispossession seems not to have been a concern.Current Issue

Subscribe today and Save up to $129.

In 2017, under the watch of the reactionary, right-to-work Governor Scott Walker, Huron was hired by the University of Wisconsinhistorically a exemplar of the state-funded, public institution serving the poor as well as the affluentto manage a state-driven austerity plan. In addition to laying off a hundred employees, reducing employment for non-tenure-track staff, and forcibly reassigning tenured faculty, Hurons plan shuttered thriving programs in humanities and social sciences and drove mass faculty layoffs at the universitys Stevens Point Campus.

The University of New Hampshire (UNH) didnt fare any better. In 2019, UNH paid Huron $600,000 to produce a cost-saving, reimagining assessment that Huron claimed would save the university $12 million over two years. The solutions proposed in the report included cuts to research and libraries, layoffs of facility and maintenance staff, and adjustments to the faculty mix (the combination of tenure track and untenured positions) based on a merely quantitative criterion for cost efficiency, credit hour production (CHP) per faculty member. CHP is the total number of credit hours produced in a semester and is calculated multiplying the number of students enrolled by the credit hour per course.

Hurons business model for restructuring higher education also emphasizes the expansion of the market through online learning and the development of global education platforms. It not only suggests that universities use the strategy of their Fortune 1000 counterparts, it advocates fostering corporate educational partnerships. This is plainly at odds with The New Schools historic commitment to promoting and defending the values of intellectual and academic freedom.

Outside of corporate and institutional boardrooms, fierce resistance to the reimagining is mounting across The New School. Employees, students, and faculty are demanding to have a voice in shaping the future of their university. In an unprecedented display of solidarity among students, faculty, and staff members, the unions present on campus (UAW Local 7902, Teamsters Local 1205, and AFM local 802) and The New Schools American Association of University Professors Chapterhave come together under the umbrella of the New School Labor Coalition, organizing a campaign to force the schools leadership to recognize the communitys needs and to bring its workers to the table.

If you like this article, please give today to help fund The Nations work.

In a couple of emotional Zoom meetings, laid-off workers described the effects of the universitys austerity measures, the imposition of what Ruth Wilson Gilmore refers to as organized abandonment. Some employees have been working at the school for up to 20 years or more, only to find themselves with no retirement, no income, and no health insurance. Underfunded graduate students expressed rage about the number of teaching fellowships that have been canceled, one of the few sources of income for international students on a visa. And an exhausted faculty body, whose salaries have been cut, retirement contributions halted, and research funds eliminated, expressed their concerns about being confronted with an institution they no longer recognize as their own.

Despite repeated requests, university leadership has yet to meet with the labor coalition. Demands for financial transparency and meaningful participation in decision-making have been similarly deflected. Crucial information has been withheld even from the task force of faculty, staff, and administrators created by the administration to help reimagine the university, leading all faculty and staff representatives in the task force to send a letter to the president and the provost explaining that they find it impossible to fulfill their mission without access to transparent and reliable data about the schools finances.

The administrations actions add up to what Naomi Klein calls the shock doctrinethe tactic of using a supposed crisis to push through radical pro-corporate measures. Corporate sharks like Huron have been helping university bosses across the country implement different versions of this austerity-driven doctrine, and The New School is clearly no exception. This vision of the future is not only borne on the backs of the most vulnerable in our communities; it threatens to undermine higher education itself. To remain true to its historical commitments, The New School needs to dispense with corporate models that cut to the bone, and begin listening to those who make the institution, against all odds, a place of humane, progressive education.

Go here to read the rest:

Corporate Consultants Set Their Targets on American Universities - The Nation

Biology is having its industrial revolution – Axios

Posted on October 23, 2020 by Danzig

Bioscience research is undergoing a wave of automation and digitization, turning a manual, laborious practice into a true industry.

Why it matters: Biotechnology promises to revolutionize everything from medicine to energy, but for that to happen, the field needs to move out of the traditional lab and into something resembling a foundry. The growth of robotics and cloud-based remote research can help make that happen.

What's happening: In a report published last week, the design and engineering firm Arup made the case that the future of scientific labs will increasingly be automated and digitized, allowing researchers to carry out experiments remotely and scale up their work faster.

How it works: That means labs where experiments can be automated think robot arms moving vials en masse, rather than overworked graduate students pipetting by hand.

Of note: Benchling, which helps life science researchers remotely track and share data, has seen a 35% increase in platform use from customers working on COVID-19.

Zoom in: Speed and industrialization in the lab are particularly vital for developing a COVID-19 vaccine in record time.

Context: Ginkgo Bioworks, which is now valued at more than $4 billion, represents the cutting edge of biotech industrialization.

What's next: On Tuesday, the Department of Defense announced it would award $87.5 million which will be matched by more than $180 million in non-federal funding to establish a manufacturing innovation institute called BioMADE at the University of Minnesota.

The bottom line: If the 21st century really is going to be the "age of biology," as some experts have predicted, the field needs to undergo its own version of the Industrial Revolution.

Go here to read the rest:
Biology is having its industrial revolution - Axios

Is Adaptimmune Therapeutics PLC – ADR (ADAP) a Winner in the Biotechnology Industry? – InvestorsObserver

Posted on October 23, 2020 by Danzig

The 55 rating InvestorsObserver gives to Adaptimmune Therapeutics PLC - ADR (ADAP) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 64 percent of stocks in the Biotechnology industry, ADAPs 55 overall rating means the stock scores better than 55 percent of all stocks.

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

Adaptimmune Therapeutics PLC - ADR (ADAP) stock has risen 12.79% while the S&P 500 is down -0.07% as of 11:50 AM on Friday, Oct 23. ADAP has gained $0.55 from the previous closing price of $4.30 on volume of 879,311 shares. Over the past year the S&P 500 is up 14.64% while ADAP has gained 444.94%. ADAP lost -$1.10 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Adaptimmune Therapeutics PLC - ADR (ADAP) Stock.

See more here:
Is Adaptimmune Therapeutics PLC - ADR (ADAP) a Winner in the Biotechnology Industry? - InvestorsObserver

Covid-19 Impact On Pharmaceutical & Biotechnology Environmental Monitoring Market : Growth, Segmentation Analysis By Application And Regions To…

Posted on October 23, 2020 by Danzig

Pharmaceutical & Biotechnology Environmental Monitoring Market 2020: Latest Analysis

Chicago, United States:- Global Pharmaceutical & Biotechnology Environmental Monitoring Market reports offers important insights which help the industry experts, product managers, CEOs, and business executives to draft their policies on various parameters including expansion, acquisition, and new product launch as well as analyzing and understanding the market trends.

Each segment of the global Pharmaceutical & Biotechnology Environmental Monitoring market is extensively evaluated in the research study. The segmental analysis offered in the report pinpoints key opportunities available in the global Pharmaceutical & Biotechnology Environmental Monitoring market through leading segments. The regional study of the global Pharmaceutical & Biotechnology Environmental Monitoring market included in the report helps readers to gain a sound understanding of the development of different geographical markets in recent years and also going forth. We have provided a detailed study on the critical dynamics of the global Pharmaceutical & Biotechnology Environmental Monitoring market, which include the market influence and market effect factors, drivers, challenges, restraints, trends, and prospects. The research study also includes other types of analysis such as qualitative and quantitative.

Global Pharmaceutical & Biotechnology Environmental Monitoring Market report offers a detailed Outlook and future prospects of the Industry. The Pharmaceutical & Biotechnology Environmental Monitoring Market report includes various topics like market size & share, Product types, applications, key market drivers & restraints, challenges, growth opportunities, key players, competitive landscape.

Top Players of Pharmaceutical & Biotechnology Environmental Monitoring Market are Studied: Danaher Corporation, Thermo Fisher Scientific, Merck KGaA, Eurofins Sinensis, Lonza, Biomerieux, VAI, Cosasco, RMONI, Amphenol Advanced Sensors, Vaisala

Download Free Sample PDF (including full TOC, Tables, and Figures) of Pharmaceutical & Biotechnology Environmental Monitoring Market Research 2020-2026:- @

Competitive landscape is a critical aspect every key player needs to be familiar with. The report throws light on the competitive scenario of the global Pharmaceutical & Biotechnology Environmental Monitoring market to know the competition at both the domestic and global levels. Market experts have also offered the outline of every leading player of the global Pharmaceutical & Biotechnology Environmental Monitoring market, considering the key aspects such as areas of operation, production, and product portfolio. Additionally, companies in the report are studied based on the key factors such as company size, market share, market growth, revenue, production volume, and profits.

NOTE:Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Pharmaceutical & Biotechnology Environmental Monitoring Market which would mention How the Covid-19 is Affecting the Pharmaceutical & Biotechnology Environmental Monitoring Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for Pharmaceutical & Biotechnology Environmental Monitoring Players to Combat Covid-19 Impact.

Environmental monitoring during pharmaceutical and biopharmaceutical production is crucial for ensuring the safety of formulated drug products. While requirements for the control of both viable (living microorganisms) and non-viable particles (e.g. dust, hair, etc.) and other contaminants (i.e. trace metals, volatiles, etc.) for aseptic manufacturing operations are more extensive than those for non-sterile processes, the quantity of samples that must be analyzed and the amount of data generated can be daunting regardless of the final drug form, particularly for global companies with multiple production facilities.

The report forecast global Pharmaceutical & Biotechnology Environmental Monitoring market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation.The report offers detailed coverage of Pharmaceutical & Biotechnology Environmental Monitoring industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Pharmaceutical & Biotechnology Environmental Monitoring by geography. The report splits the market size, by volume and value, on the basis of application type and geography.First, this report covers the present status and the future prospects of the global Pharmaceutical & Biotechnology Environmental Monitoring market for 2015-2024.And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].At the same time, we classify Pharmaceutical & Biotechnology Environmental Monitoring according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.Finally, the report provides detailed profile and data information analysis of leading Pharmaceutical & Biotechnology Environmental Monitoring company.

Our exploration specialists acutely ascertain the significant aspects of the global Pharmaceutical & Biotechnology Environmental Monitoring market report. It also provides an in-depth valuation in regards to the future advancements relying on the past data and present circumstance of Pharmaceutical & Biotechnology Environmental Monitoring market situation. In this Pharmaceutical & Biotechnology Environmental Monitoring report, we have investigated the principals, players in the market, geological regions, product type, and market end-client applications. The global Pharmaceutical & Biotechnology Environmental Monitoring report comprises of primary and secondary data which is exemplified in the form of pie outlines, Pharmaceutical & Biotechnology Environmental Monitoring tables, analytical figures, and reference diagrams. The Pharmaceutical & Biotechnology Environmental Monitoring report is presented in an efficient way that involves basic dialect, basic Pharmaceutical & Biotechnology Environmental Monitoring outline, agreements, and certain facts as per solace and comprehension.

Segmentation by Application: Pharmaceutical IndustryBiotechnology IndustryAcademic & Research Institutes

Segmentation by Type: Monitoring EquipmentMediaSoftwareMicrobiology Services

The Essential Content Covered in the GlobalPharmaceutical & Biotechnology Environmental Monitoring Market Report:

* Top Key Company Profiles.* Main Business and Rival Information* SWOT Analysis and PESTEL Analysis* Production, Sales, Revenue, Price and Gross Margin* Market Share and Size

Regional Coverage: North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Some Main Reasons For Purchasing This Report:

Readers of this report will receive in-depth knowledge about the market.

Updated statistics offered on the global Pharmaceutical & Biotechnology Environmental Monitoring market report.

This report provides an insight into the market that will help you boost your companys business and sales activities.

It will help you to find prospective partners and suppliers.

It will assist and strengthen your companys decision-making processes.

Get Full Customize report or for any Special Discount [emailprotected] @ https://www.reporthive.com/request_customization/2501701

Table of Contents

Market Overview: This is the first section of the report that includes an overview of the scope of products offered in the global Pharmaceutical & Biotechnology Environmental Monitoring market, segments by product and application, and market size.

Market Competition by Player: Here, the report shows how the competition in the global Pharmaceutical & Biotechnology Environmental Monitoring market is growing or decreasing based on deep analysis of market concentrate rate, competitive situations and trends, expansions, merger and acquisition deals, and other subjects. It also shows how different companies are progressing in the global Pharmaceutical & Biotechnology Environmental Monitoring market in terms of revenue, production, sales, and market share.

Company Profiles and Sales Data: This part of the report is very important as it gives statistical as well as other types of analysis of leading manufacturers in the global Pharmaceutical & Biotechnology Environmental Monitoring market. It assesses each and every player studied in the report on the basis of main business, gross margin, revenue, sales, price, competitors, manufacturing base, product specification, product application, and product category.

Market Status and Outlook by Region: The report studies the status and outlook of different regional markets such as Europe, North America, the MEA, Asia Pacific, and South America. All of the regional markets researched about in the report are examined based on price, gross margin, revenue, production, and sales. Here, the size and CAGR of the regional markets are also provided.

Market by Product: This section carefully analyzes all product segments of the global Pharmaceutical & Biotechnology Environmental Monitoring market.

Market by Application: Here, various application segments of the global Pharmaceutical & Biotechnology Environmental Monitoring market are taken into account for research study.

Market Forecast: It starts with revenue forecast and then continues with sales, sales growth rate, and revenue growth rate forecasts of the global Pharmaceutical & Biotechnology Environmental Monitoring market. The forecasts are also provided taking into consideration product, application, and regional segments of the global Pharmaceutical & Biotechnology Environmental Monitoring market.

Upstream Raw Materials: This section includes industrial chain analysis, manufacturing cost structure analysis, and key raw materials analysis of the global Pharmaceutical & Biotechnology Environmental Monitoring market.

Marketing Strategy Analysis, Distributors: Here, the research study digs deep into behavior and other factors of downstream customers, distributors, development trends of marketing channels, and marketing channels such as indirect marketing and direct marketing.

Research Findings and Conclusion: This section is solely dedicated to the conclusion and findings of the research study on the global Pharmaceutical & Biotechnology Environmental Monitoring market.

Appendix: This is the last section of the report that focuses on data sources, viz. primary and secondary sources, market breakdown and data triangulation, market size estimation, research programs and design, research approach and methodology, and the publishers disclaimer.

Get Free Sample Copy of this report: https://www.reporthive.com/request_sample/2501701

Why Go For Report Hive Research?Report Hive Research delivers strategic market research reports, statistical surveys, industry analysis and forecast data on products and services, markets and companies. Our clientele ranges mix of global business leaders, government organizations, SMEs, individuals and Start-ups, top management consulting firms, universities, etc. Our library of 700,000 + reports targets high growth emerging markets in the USA, Europe Middle East, Africa, Asia Pacific covering industries like IT, Telecom, Semiconductor, Chemical, Healthcare, Pharmaceutical, Energy and Power, Manufacturing, Automotive and Transportation, Food and Beverages, etc. This large collection of insightful reports assists clients to stay ahead of time and competition. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales and revenue, technology trends, competitive analysis, product portfolio, and application analysis, etc.

Pharmaceutical & Biotechnology Environmental Monitoring Market Forecast, Pharmaceutical & Biotechnology Environmental Monitoring Market Trends, Pharmaceutical & Biotechnology Environmental Monitoring Market Research, Pharmaceutical & Biotechnology Environmental Monitoring, Pharmaceutical & Biotechnology Environmental Monitoring Market Analysis, Pharmaceutical & Biotechnology Environmental Monitoring application, Pharmaceutical & Biotechnology Environmental Monitoring Market CAGR Competitive Landscape, Pharmaceutical & Biotechnology Environmental Monitoring Market Growth

Get in Touch with Us :

Report Hive Research

Website: https://www.reporthive.com

Email: [emailprotected]

Speak to Research Analyst: +1-312-604-7084

See more here:
Covid-19 Impact On Pharmaceutical & Biotechnology Environmental Monitoring Market : Growth, Segmentation Analysis By Application And Regions To...

Is Cardiff Oncology Inc (CRDF) a Winner in the Biotechnology Industry? – InvestorsObserver

Posted on October 23, 2020 by Danzig

Cardiff Oncology Inc (CRDF) is around the top of the Biotechnology industry according to InvestorsObserver. CRDF received an overall rating of 89, which means that it scores higher than 89 percent of all stocks. Cardiff Oncology Inc also achieved a score of 99 in the Biotechnology industry, putting it above 99 percent of Biotechnology stocks. Biotechnology is ranked 31 out of the 148 industries.

Finding the best stocks can be tricky. It isnt easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObservers tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.

Cardiff Oncology Inc (CRDF) stock is trading at $13.30 as of 11:34 AM on Thursday, Oct 22, a gain of $1.28, or 10.65% from the previous closing price of $12.02. The stock has traded between $12.50 and $13.41 so far today. Volume today is below average. So far 427,977 shares have traded compared to average volume of 3,743,546 shares.

Click Here to get the full Stock Score Report on Cardiff Oncology Inc (CRDF) Stock.

Continue reading here:
Is Cardiff Oncology Inc (CRDF) a Winner in the Biotechnology Industry? - InvestorsObserver

Is Adaptimmune Therapeutics PLC – ADR (ADAP) The Right Choice in Biotechnology? – InvestorsObserver

Posted on October 23, 2020 by Danzig

The 56 rating InvestorsObserver gives to Adaptimmune Therapeutics PLC - ADR (ADAP) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 66 percent of stocks in the Biotechnology industry, ADAPs 56 overall rating means the stock scores better than 56 percent of all stocks.

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 56 would rank higher than 56 percent of all stocks.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

Adaptimmune Therapeutics PLC - ADR (ADAP) stock is down -2.65% while the S&P 500 is higher by 0.14% as of 11:42 AM on Thursday, Oct 22. ADAP has fallen -$0.12 from the previous closing price of $4.53 on volume of 1,246,466 shares. Over the past year the S&P 500 has risen 14.50% while ADAP is higher by 345.45%. ADAP lost -$1.10 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Adaptimmune Therapeutics PLC - ADR (ADAP) Stock.

The rest is here:
Is Adaptimmune Therapeutics PLC - ADR (ADAP) The Right Choice in Biotechnology? - InvestorsObserver

Latest Joint Venture Agreements Announced in the Pharmaceutical, Biotechnology and Diagnostic, 2020 – Virtual-Strategy Magazine

Posted on October 23, 2020 by Danzig

DUBLIN, Oct. 20, 2020 The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020 report has been added to ResearchAndMarkets.coms offering.

This report provides details of the latest joint venture agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully up to date, the report provides details of joint venture agreements from 2014.

There is an increasing willingness for parties to enter joint venture deals; such deals enable both parties to benefit from the upside of a big product win, whereas traditional licensing deals forfeit upside for near term upfront, milestone and royalty payments.

Joint venture partnering allow the parties to securitize value and reduce risk, but keep a part of the potential upside should the product reach the market. Event if the licensor does not commercialize the project they can either sell those rights to the licensee partner or another partner for an amount higher than would have been achieved at an earlier stage licensing deal.

Another reason for joint venture deals is the joint origin of a project. Drug development projects often require various scientific and technological novelties that stem from different companies. If both companies contributed to the origination of the project, then both have from the beginning a stake in the project.

The report provides a detailed understanding and analysis of how and why companies enter joint venture deals.

Understanding the flexibility of a prospective partners negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of all joint venture deals announced since 2014 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual joint venture contract documents as submitted to the Securities Exchange Commission by companies and their partners.

Contract documents provide the answers to numerous questions about a prospective partners flexibility on a wide range of important issues, many of which will have a significant impact on each partys ability to derive value from the deal.

The appendices to the report includes a comprehensive listing of all Joint venture deals announced since 2014. Each listing is organized as an appendix by company A-Z, stage of development at signing, therapeutic area and industry type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in Joint venture dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about Joint venture alliances.

Key benefits

Available deals and contracts are listed by:

Key Topics Covered:

Executive Summary

Chapter 1 Introduction

Chapter 2 Trends in joint venture partnerships2.1. Introduction2.2. Definition of joint venture deals2.3. Success factors for joint venture partnerships2.4. When joint venture partnerships can be useful2.5. Attributes of joint venture partnerships2.6. Aligning partners to make the joint venture work2.7. Trends in joint venture partnerships since 20142.7.1. Joint venture dealmaking by year, 2014 to 20202.7.2. Joint venture dealmaking by stage of development 2014 to 20202.7.3. Joint venture dealmaking by industry sector 2014 to 20202.7.4. Joint venture dealmaking by therapy area, 2014 to 20202.7.5. Joint venture dealmaking by technology type, 2014 to 20202.7.6. Joint venture dealmaking by most active company, 2014 to 20202.8. The future of joint venture partnerships

Chapter 3 Overview of joint venture deal structure3.1. Introduction3.2. Joint venture agreement structure3.3. Example joint venture agreements3.3.1. Case study 1: Agila Specialties Pfenex3.3.2. Case study 2: Dance Biopharm Harmony Asset

Chapter 4 Leading joint venture deals4.1. Introduction4.2. Top joint venture deals by value

Chapter 5 Top 25 most active active joint venture dealmakers5.1. Introduction5.2. Top 25 most active joint venture dealmakers

Chapter 6 Joint venture deals including contracts directory6.1. Introduction6.2. Joint venture deals with contracts 2014 to 2020

AppendicesAppendix 1 Joint venture dealmaking by companies A-ZAppendix 2 Joint venture dealmaking by industry sectorAppendix 3 Joint venture dealmaking by stage of developmentAppendix 4 Joint venture dealmaking by therapy areaAppendix 5 Joint venture dealmaking by technology typeAppendix 6 Joint venture referencesAppendix 7 ResourcesAppendix 8 Deal type definitions

For more information about this report visit https://www.researchandmarkets.com/r/b8myyj

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

Follow this link:
Latest Joint Venture Agreements Announced in the Pharmaceutical, Biotechnology and Diagnostic, 2020 - Virtual-Strategy Magazine

SQZ Biotech Strengthens Board of Directors and Appoints New Chief Business Officer – BioSpace

Posted on October 23, 2020 by Danzig

Oct. 23, 2020 12:00 UTC

Marc Schegerin, MD and Sapna Srivastava, PhD join as new board members and Micah Zajic as Chief Business Officer

WATERTOWN, Mass.--(BUSINESS WIRE)-- SQZ Biotech (SQZ), a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases and other serious conditions, today announced the appointments of Marc Schegerin, MD and Sapna Srivastava, PhD to its board of directors as well as Micah Zajic as chief business officer.

Its an honor to have Marc and Sapna join our board of directors. Their senior leadership experience in the biotech and healthcare fields will be invaluable as we continue to execute on our long-term vision to create novel, impactful cell therapies for patients in need, said Armon Sharei, PhD, founder and chief executive officer of SQZ. In addition, I am pleased to welcome Micah to our team during this pivotal time in our evolution. His diverse experience in biotech and corporate finance will provide us with strategic insight and strong leadership as we continue to develop our pipeline and manage our strategic partnerships.

Dr. Schegerin joins the SQZ board of directors with a wealth of experience in the healthcare and financial industries. He is currently chief financial officer and chief operating officer at Morphic Therapeutics. Before joining Morphic, Dr. Schegerin served as chief financial officer, and head of strategy at ArQule, until its acquisition by Merck for $2.7 billion. Prior to ArQule, Dr. Schegerin served in various senior healthcare investment banking roles at CitiGroup, Bank of America Merrill Lynch, and Goldman Sachs. Dr. Schegerin has also held industry management roles at Biogen and Sage Therapeutics. Dr. Schegerin earned his MD from Dartmouth Medical School (Payson/Hampers Scholar) and his MBA from the Tuck School of Business at Dartmouth (Don Wilson, III scholar).

Dr. Srivastava was most recently the chief financial and strategy officer for Abide Therapeutics, which was acquired by Lundbeck. Previously Dr. Srivastava served as chief financial and strategy officer for Intellia, where she played an integral role in launching the companys financial operations and strategic direction and spearheading its initial public offering. Additionally, Dr. Srivastava has nearly 15 years of experience as a research analyst in the biotechnology sector, which includes her work at Goldman Sachs, Morgan Stanley, ThinkEquity Partners, and JP Morgan. Dr. Srivastava also has experience as an independent board member and advisor to several biotechnology companies and non-profit organizations. Dr. Srivastava received her PhD in neuroscience from New York University and her bachelors from St. Xavier's College in India.

We are thrilled to have both Dr. Schegerin and Dr. Srivastava join our board, said Amy Schulman, chair of the board of directors at SQZ. Both have diverse experience within the biotechnology industry and have demonstrated success across the spectrum of both finance and healthcare, which bolsters our boards expertise as we navigate the companys next phase of growth.

Micah Zajic joins SQZ as chief business officer with over 15 years of experience in biotech and corporate development. He most recently served as vice president of corporate development at MeiraGTx and was responsible for all business development activities. Prior to MeiraGTx, Mr. Zajic worked at Alexion Pharmaceuticals, where he was primarily focused on the evaluation and execution of external partnerships, license agreements, and acquisitions. He started his career in Morgan Stanley's Global Capital Markets and Healthcare Investment Banking Group. Mr. Zajic received his bachelors in economics from Georgetown University.

About SQZ Biotech

SQZ Biotech is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. Using its proprietary technology, SQZ has the unique ability to deliver multiple materials into many patient cell types to engineer what we believe to be an unprecedented range of potential therapeutics for a range of diseases. SQZ has the potential to create well-tolerated cell therapies that can provide therapeutic benefit for patients and potentially improve the patient experience over existing cell therapy approaches, with accelerated production timelines under 24 hours and the elimination of pre-conditioning and lengthy hospital stays. Our goal is to use the SQZ approach to establish a new paradigm for cell therapies. The first therapeutic applications leverage SQZs ability to generate target-specific immune responses, both in activation for the treatment of solid tumors and immune tolerance for the treatment of unwanted immune reactions and autoimmune diseases. For more information please visit http://www.sqzbiotech.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201023005055/en/

Is Aileron Therapeutics Inc (ALRN) Stock Near the Top of the Biotechnology Industry? – InvestorsObserver

Posted on October 23, 2020 by Danzig

Aileron Therapeutics Inc (ALRN) is around the top of the Biotechnology industry according to InvestorsObserver. ALRN received an overall rating of 94, which means that it scores higher than 94 percent of all stocks. Aileron Therapeutics Inc also achieved a score of 100 in the Biotechnology industry, putting it above 100 percent of Biotechnology stocks. Biotechnology is ranked 31 out of the 148 industries.

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 94 would rank higher than 94 percent of all stocks.

Aileron Therapeutics Inc (ALRN) stock is trading at $2.09 as of 10:17 AM on Thursday, Oct 22, a rise of $0.06, or 3.21% from the previous closing price of $2.03. The stock has traded between $2.06 and $2.21 so far today. Volume today is low. So far 240,889 shares have traded compared to average volume of 906,744 shares.

Click Here to get the full Stock Score Report on Aileron Therapeutics Inc (ALRN) Stock.

Read this article:
Is Aileron Therapeutics Inc (ALRN) Stock Near the Top of the Biotechnology Industry? - InvestorsObserver

Stem Cells in Regenerative Medicine: The Next Frontier in Biotechnology – The Think Curiouser

Posted on October 23, 2020 by Danzig

The proposed Pre-Loaded Intraocular Lens Market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints, technological advancements & competitive landscape along with various micro & macro factors influencing the market dynamics.

The Pre-Loaded Intraocular Lens Market sample report includes an exclusive analysis of COVID-19 pandemic on the market space under scrutiny. The sample represents the format of the overall study which is designed to provide clarity on the structure of the report and some data points demonstrated in an attempt to provide insights into the study quality.

Furthermore, the Pre-Loaded Intraocular Lens Market full research study is designed on account of the fact that each segment is individually assessed and then collated to form the whole market, the study can be tailor-made to fit your exact requirements.

Request Sample Pages of this research study at https://www.theinsightpartners.com/sample/TIPRE00015245/

The structure of the Pre-Loaded Intraocular Lens Market report can be categorized into following sections:

The Prominent/Emerging Players in the Pre-Loaded Intraocular Lens Market Research include:

The Pre-Loaded Intraocular Lens Market Company Profiles are individually represented for all major participants and indices such as Financial Performance, Strategic Initiatives, Product Portfolio & Company Overview.

Company Overview:

Company overview provides the information about location of the company where it is headquartered along with the established year, employee strength as of 2017, regions where the company is operating and the key business areas.

Financial Performance:

Overall company/segment revenue for the year 2019, 2018, and 2017 is provided in the sub title Financial Performance (public listed companies) along with the analysis and explanation of the increase or decrease in the same due to factors such as mergers & acquisition, profit or loss in any strategic business unit (SBUs) and others.

Product Benchmarking:

Product benchmarking comprises the comprehensive list of products pertaining to the respective market along with the application and key features.

Strategic Initiatives:

Insights pertaining to the new product launch, strategic collaboration, mergers and acquisition, regulatory approval, and other developments by the company in market are covered under strategic initiatives section.

Order a copy of this research study at https://www.theinsightpartners.com/buy/TIPRE00015245/

The Pre-Loaded Intraocular Lens Market research study is designed keeping in focus all the major countries. Although, all these countries & their market trends were accounted for while composing it, detailed sections are available for only the spearheads. In case if you would be interested in specific countries which are not covered in the current scope, kindly share the list & we can customize the study based on the geographical scope defined by you.

ABOUT US:

The Insight Partners is a one stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Our research model is very simple. We believe in client servicing and delivering best quality to our customers. Through our research content, we are making sure that our customers get value of their money along with better quality data and analysis.

Our research content is majorly focused towards market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis etc. We provide detailed break-up of segmentation in terms of geography, technology, product and services etc.; which helps our clients to get a deeper analysis on various research topics.About Us:

If you have any queries about this report or would like further information, please contact us:

North America: +1 646 491 9876

Asia-Pacific: +91 20 6727 8686

Email: [emailprotected]

Read the original post:
Stem Cells in Regenerative Medicine: The Next Frontier in Biotechnology - The Think Curiouser

Global Agricultural Biotechnology Market Size, Market Research and Industry Forecast Report, 2025 (Includes Business Impact of COVID-19) – Eurowire

Posted on October 23, 2020 by Danzig

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Agricultural Biotechnology market.

Trusted Business Insights presents an updated and Latest Study on Agricultural Biotechnology Market. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market.The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Agricultural Biotechnology market during the forecast period.It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.

Get Sample Copy of this Report @ Global Agricultural Biotechnology Market Size, Market Research and Industry Forecast Report, 2025 (Includes Business Impact of COVID-19)

Industry Insights, Market Size, CAGR, High-Level Analysis: Global Agricultural Biotechnology Market

The global agricultural biotechnology market size was estimated at USD 89.89 billion in 2018 and is projected to grow at a CAGR of 7.07% during the forecast period. An increase in demand for new breeding techniques is expected to propel the market growth. This is supplemented by increasing penetration of biotechnology tools to create or modify traits of organisms-including plants, animals, and microbes-with respect to color, yield, or size.Biotechnology tools are gaining significant demand across agricultural applications. These include tissue culture and micropropagation, marker-assisted selection or molecular breeding, genetically modified crops & genetic engineering, molecular diagnostic technologies, and conventional plant breeding.

A rise in the adoption of Genetically Modified (GM) crops globally is expected to drive the market throughout the forecast period. This is because genetic modification allows the production of feed and food crops with enhanced characteristics such as high nutritional value, high yield, enhanced food-processing qualities, and resistance against diseases and insects. In many countries, GM crops have been adopted rapidly, and the market for insect-resistant, herbicide-tolerant GM seeds is among the growing sectors of the agricultural industry.According to the estimates of International Service for the Acquisition of Agri-biotech Applications (ISAAA), 2.15 billion hectares of biotechnology crops have been commercially grown from 1996 to 2016. This includes 0.34 billion hectares of biotechnology cotton, 1.04 billion hectares of biotechnology soybean, 0.13 billion hectares of biotechnology canola, and 0.64 billion hectares of biotechnology maize. These products contribute to a major portion of fiber, feed, fuel, and food consumption globally.

Application Insights of Global Agricultural Biotechnology Market

The agricultural biotechnology market is classified into six segments based on application, namely vaccine development, transgenic crops & animals, antibiotic development, nutritional supplements, flower culturing, and biofuels. Transgenic crops & animals segment generated the highest revenue in 2018 while vaccine development is estimated to witness fastest growth than other applications.Agricultural biotechnology has helped in livestock as well as crop enhancement via incorporating advanced tools. Agriculture-integrated biotechnology finds vast applications across tissue culture, micropropagation, embryo transfer, cloning, and artificial insemination among others. Biotechnology tools have been applied successfully in micropropagation of disease-free plants, improving aluminum tolerance, crop fortification, and genetic modification in crops.OrganismType Insights of Global Agricultural Biotechnology Market

Agricultural biotechnology involves the use of a broad range of modern techniques to develop innovative products with enhanced quality traits. Conventional breeding techniques have been adopted largely to carry out alterations in plant and animal genomes. In addition, advancements in the field of genetic engineering have enabled controlling of genetic changes induced into the organism.Advanced biotechnology tools have enabled professionals to incorporate new genes from one species to another unrelated species targeting towards the optimization of agricultural production or manufacturing valuable pharmaceutical compounds. The most common subjects of genetic engineering include farm animals, crops, and soil bacteria.

The global agricultural biotechnology market is classified into three segments based on the organism: plants, animals, and microbes. The plants segment has generated the largest revenue in 2018 and is expected to maintain its dominance throughout the forecast period. Whereas animals segment is expected to grow at the fastest CAGR in the coming years. Each of the segments of organism outlook is further classified into three segments based on techniques; conventional techniques, established genetic modification, and new breeding techniques.

Regional Insights of Global Agricultural Biotechnology Market

North America dominated with the largest revenue share in 2018, owing to its wide range of agro-climatic zones and crops, along with a large global Genetically Modified (GM) planted area. In this region, the U.S. and Canada together represent around 50% of the global GM area and around 10% global planted area. Major crops cultivated in around 70% of the cultivated area of North America include corn, soybean, and wheat, followed by alfalfa, cotton, canola, & barley. Moreover, North America is a net exporter of agricultural products with around 30% production of corn, soybean, and wheat globally.Whereas, Asia Pacific is expected to grow at the fastest pace during the forecast period. This region is characterized by the presence of several with different political & economic systems, cultural backgrounds, and languages. Within these, the agricultural industry varies from the adoption of high technical standards in Japan to basic systems in India.Asia Pacific serves as a lucrative market as the region occupies nearly 40% of the global cropped area (nearly 600 million hectares). The region is also characterized by the importance of rice crop (except Australasia), and the predominance of smallholders. Rice is available at highly subsidized rates across Asia and food security is a major concern for local governments in most of its developing economies. The region holds nearly 90% of the total crop area for rice, with 20% and 28% in China and India respectively.Agricultural Biotechnology Market InsightsKey players in the market include KWS SAAT SE & Co. KGaA, ChemChina, Limagrain, Nufarm, Marrone Bio Innovations, Performance Plants Inc., Corteva, ADAMA Ltd, MITSUI & CO., LTD, Evogene Ltd., Valent BioSciences LLC, and Bayer AG. These companies are adopting several strategies to maintain their market presence.Over the years, the market has witnessed a substantial number of product launches. For instance, in July 2019, KWS SAAT SE & Co. KGaA launched six new hybrid corn varieties as part of its brands, KWS and Riber, in Brazil. These varieties provide high genetic protection against insects, high yield, and tolerance against herbicides. This launch allowed the company to provide an innovative portfolio of seeds to Brazilian farmers, thereby improving their presence in Brazil.

Segmentations, Sub Segmentations, CAGR, & High-Level Analysis overview of Global Agricultural Biotechnology Market Research ReportThis report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, this market research report has segmented the global agricultural biotechnology market report on the basis of application, organism type, and region:

Application Outlook (Revenue, USD Billion, 2019 2030)

Vaccine Development

Transgenic Crops & Animals

Antibiotic Development

Nutritional Supplements

Flower Culturing

Biofuels

Organism Type Outlook (Revenue, USD Billion, 2019 2030)

Plants

Conventional Techniques

Established Genetic Modification

New Breeding Techniques

Animals

Conventional Techniques

Established Genetic Modification

New Breeding Techniques

Microbes

Conventional Techniques

Established Genetic Modification

New Breeding Techniques

Looking for more? Check out our repository for all available reports on Agricultural Biotechnology in related sectors.

Quick Read Table of Contents of this Report @ Global Agricultural Biotechnology Market Size, Market Research and Industry Forecast Report, 2025 (Includes Business Impact of COVID-19)

Trusted Business InsightsShelly ArnoldMedia & Marketing ExecutiveEmail Me For Any ClarificationsConnect on LinkedInClick to follow Trusted Business Insights LinkedIn for Market Data and Updates.US: +1 646 568 9797UK: +44 330 808 0580

The rest is here:
Global Agricultural Biotechnology Market Size, Market Research and Industry Forecast Report, 2025 (Includes Business Impact of COVID-19) - Eurowire

Top Insights on the Separation Systems for Commercial Biotechnology Market Leading Key Players – TechnoWeekly

Posted on October 23, 2020 by Danzig

Global Separation Systems for Commercial BiotechnologyMarket 2020-2026 Key Challenges. Industry Risks and Worldwide Opportunities during Covid-19.

Market Research Vision published latest Research Report on Global Separation Systems for Commercial BiotechnologyMarket 2020. Research study explores economical impact of pandemic on Separation Systems for Commercial Biotechnologyindustry Segment as follows:

By Important Manufacturers Player 1, Player2, Player 3

Get Latest Sample Report of Global Separation Systems for Commercial BiotechnologyMarket 2020-2026: https://www.marketresearchvision.com/request-sample/543028

The report has segmented market 20202025 into different components on the basis of products, Application, geography and end users wherever needed. With thorough analysis and detailed study of past, present and future market 20162021 conditions, the report is able to delivery factual and reliable information to the users.

By Region / Countries

Click here to Get customization & check discount for the report @ https://www.marketresearchvision.com/check-discount/543028

Our Research Experts have made this insightful report on Separation Systems for Commercial Biotechnologymarket, which is available for user on the site of Market Research Vision. The report carries various factors and elements of the industry in picture, all around the globe, be it its potential or probable threat to its growth or simply the way and method of its functioning during covid-19.

About Market Research Vision

We at Market Research Vision provides a study of products, services, technologies, applications, end users, market dynamics, and market players for global, regional, and country level market segments. Our team widely focuses on market dynamics and identifies new opportunities to rely on. We serve several fortune 500 clients along with various small and large companies. We serve in several domains such as aerospace and defense, automotive and transportation, banking & finance, construction & manufacturing, machinery & equipment, company profiles, consumer goods, food and beverages, ICT media, energy & power, materials and chemicals, medical devices, pharmaceuticals & healthcare, and semiconductor & electronics.

Fill FREE with your queries to get a call from our research expert @https://www.marketresearchvision.com/reports/543028/Separation-Systems-for-Commercial-Biotechnology-Market

Mr. Elvis Fernandes

Phone:

+1 513 549 5911 (US)

+44 203 318 3219 (UK)

Email: [emailprotected]

The rest is here:
Top Insights on the Separation Systems for Commercial Biotechnology Market Leading Key Players - TechnoWeekly

Industrial Biotechnology Market 2019 By Business Opportunity, Innovations, Applications, Upcoming-Trends, Growth-Analysis, Demand-Insight,…

Posted on October 23, 2020 by Danzig

The latest market report published by Reports and Data, titled Global Industrial Biotechnology Market, presents an accurate analysis of the estimated market size, share, revenue, and sales & distribution networks of the global Industrial Biotechnology market over the forecast period. The report offers an exhaustive overview of the market, along with a precise summary of the markets leading regions. Our team of analysts has studied the existing competitive landscape of the market inside out, focusing on the leading companies and their business expansion strategies. The report ends with conclusive data offering useful insights into the market growth on both regional and global levels.

The report covers extensive analysis of the key market players in the market, along with their business overview, expansion plans, and strategies. The key players studied in the report include:

BASF, Amyris, Borregaard, BioAmber, Codexis, Evolva, Fermentalg, Gevo, Global Bioenergies, Deinove, Metabolic Explorer, Novozymes, and Solazyme

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1338

The report draws the focus of the reader on the grave impact of the ongoing COVID-19 pandemic on the Industrial Biotechnology industry and its vital segments and sub-segments. It elaborates on the adverse effects of the pandemic on the global economic scenario, as well as this particular business sphere. The report takes into account the key influencing factors influencing market performance in the present COVID-19 times. The market has been substantially affected by the pandemic, and significant changes have been observed in the market dynamics and demand trends. The report examines the major financial difficulties brought about by the pandemic and offers a future COVID-19 impact assessment.

The market intelligence study takes the reader through the key parameters of the Industrial Biotechnology market, including the strengths and weaknesses of the leading players, using analytical tools like the SWOT analysis and Porters Five Forces analysis. The report includes broad market segmentation based on the different product types, a wide application spectrum, the key regions, and the existing competition among players.

Type Outlook (Revenue, USD Million; 2016-2026)BiofuelBiochemicalBiomaterialBioType

Raw Material Outlook (Revenue, USD Million; 2016-2026)Grains & Starch CropsAgricultural ResiduesFood WasteForestry MaterialAnimal By-TypeEnergy CropsUrban & Suburban Waste

Application Outlook (Revenue, USD Million; 2016-2026)Food & FeedPharmaceuticalsPulp & PaperTextileBio Energy

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1338

The investigative study further assesses the market on the basis of market reach and consumer base in the key geographical segments. Alongside reviewing the sales network, distribution channels, pricing analysis, profit margins, cost and demand volatility, import/export dynamics, gross revenue, and various other aspects of the market, the report studies several factors affecting market growth over the forecast period, such as drivers, restraints, limitations, growth prospects, and numerous macro- and micro-economic indicators.

Key Geographies Encompassed in the Report:

Key questions addressed in the report:

To read more about the report, visit @ https://www.reportsanddata.com/report-detail/industrial-biotechnology-market

Thank you for reading our report. For further queries regarding the report, please get in touch with us. Our team will ensure your report is customized as per your requirements.

About Us:

Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and development analysis, and demand estimation among others, we can help you invest your funds in the most beneficial areas for research and development. You can rely on us to provide every significant detail you might need in your efforts to make your business flourish.

John Watson

Head of Business Development

Reports and Data|Web:www.reportsanddata.com

Direct Line:+1-212-710-1370

E-mail:[emailprotected]

See the original post here:
Industrial Biotechnology Market 2019 By Business Opportunity, Innovations, Applications, Upcoming-Trends, Growth-Analysis, Demand-Insight,...

Virus Purification Kits Market: Consistent Expansion of Biopharmaceutical and Biotechnology Industries Boosts the Global Market – Eurowire

Posted on October 23, 2020 by Danzig

Virus Purification Kits Market: Introduction

Transparency Market Research has published a new report titled Virus Purification Kits Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 20202030. According to the report, the global virus purification kits market was valued at US$ 1.1 Bn in 2019. It is expected to expand at a CAGR of ~11% during the forecast period from 2020 to 2030. Recombinant viral vectors are highly promising tools for both in vitro and in vivo gene transfer, and oncolytic virus show encouraging results for cancer & other related treatment.

Virus purification kits provide fast and simple procedures to concentrate and purify viral vectors from cell lysate and cell culture media. A large number of vaccines are produced from cell-culture derived virus particles. Downstream purification strategies can be expensive and account for 70% of the overall manufacturing costs, which has been fueling the demand for innovative technologies for virus purification in the last few years. North America dominated the global virus purification kits market, in terms of revenue, in 2019. It is expected to continue its market dominance by the end of 2030.

Request Brochure of Report https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=36002

Rise in Research Funding by Public and Private Players to Drive Market

R&D is a vital source of innovation, as it contributes to critical knowledge-based assets as well as strengthens absorptive capacities. Furthermore, an increase in competition in the market is prompting companies to focus on R&D by allocating more resources, both in the form of investments and trained workforce. For instance, Danaher Corporations investment in research & development increased from ~US$ 956 Mn in 2017 to US$ 1.1 Bn in 2019. The higher yield of virus particles received with the help of virus purification kits is also fuelling the global virus purification kits market.

Increase in support from governmental bodies for biotechnology and pharmaceutical industries and consistent expansion of biopharmaceutical & biotechnology industries are major factors driving the global virus purification kits market.

Chromatography to be Lucrative Technology

Based on technology, the global virus purification kits market has been divided into ultracentrifugation, chromatography, nanofiltration, and others. The ultracentrifugation segment dominated the global virus purification kits market due to cost-effective methods and the availability of a large number of products by major companies. Chromatography is likely to be a highly lucrative segment during the forecast period, owing to faster processing time, higher recovery rate of virus, simple methods, and highly purified virus offered by this technology.

Request for Analysis of COVID-19 Impact on Virus Purification Kits Market https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=36002

Adenovirus Dominated Global Market

In terms of virus type, the global virus purification kits market has been segmented into adenovirus, lentivirus, retrovirus, and others. The adenovirus segment accounted for a major share of the market in 2019. It is expected to dominate the global virus purification kits market by 2030. Higher yield of adenovirus particles by latest virus purification kits, major application in viral vector based drugs, and rising incidence of adenoviruses-associated respiratory diseases are key drivers of the segment.

Contract Research Organizations (CROs) to be Promising End User

Based on end user, the global virus purification kits market has been divided into academic & research institutes, biopharmaceutical & biotechnology companies, contract research organizations (CROs), and others. The biopharmaceutical & biotechnology companies segment dominated the global virus purification kits market in 2019 due to the rise in adoption of biotherapeutics across the globe and research activities for drug discovery. Contract research organizations (CROs) is a highly lucrative segment, which is expected to expand at a high CAGR during the forecast period, owing to investments in R&D and initiation of research projects across the globe.

North America to Lead Global Market

In terms of region, the global virus purification kits market has been divided into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a major share of the global virus purification kits market in 2019, owing to favorable policies & regulatory scenario established by governments for biopharmaceutical industries in the region, highly developed healthcare sector, increase in preference for biopharmaceuticals over conventional counterparts, and continuous evolution of technology. A survey report conducted by Pharmaceutical Researchers and Manufacturers of America (PhRMA) indicated that the total pharmaceutical R&D expenditure in the U.S. was US$ 48.6 Bn in 2011, which increased to US$ 71.4 Bn in 2017. The market in Asia Pacific is projected to expand at a high CAGR during the forecast period due to the expansion of the healthcare sector, growing clinical trials for new drug development, and low cost of products and labor in the region.

Buy Virus Purification Kits Market Report https://www.transparencymarketresearch.com/checkout.php?rep_id=36002&ltype=S

Competition Landscape

The global virus purification kits market is fragmented in terms of number of players with entry of several new players in recent years. Key players in the global market include Merck KGaA, Danaher Corporation, Thermo Fisher Scientific, Inc., Sartorius AG, Lonza Group Ltd., Asahi Kasei Corporation, BioVision Inc., PendoTECH, QIAGEN, and Takara Bio Inc. Mergers, acquisitions & strategic collaborations, and new product & technology launches in recent years have been major strategies adopted by major companies in the virus purification kits market.

More Trending Reports by Transparency Market Research

Erectile Dysfunction Treatment Devices Market: https://www.biospace.com/article/-erectile-dysfunction-treatment-devices-market-lessening-stigma-and-more-awareness-likely-to-drive-the-growth-tmr/

Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

The rest is here:
Virus Purification Kits Market: Consistent Expansion of Biopharmaceutical and Biotechnology Industries Boosts the Global Market - Eurowire

Futurist Transhuman News Blog

Author Archives: Danzig

Where They Stand: John Jacob – Daily Journal

Last Week in Slovenia: 16-22 October, 2020 – Total Slovenia News

Taxpayer Tricks and Treats for Halloween 2020 – Business Wire

Letters to the editor – News – The Hutchinson News

Rep. Cynthia Lummis Speaks to Voters in Thermopolis | – mybighornbasin

Parliament body: Freedom Fighters’ monthly honorarium to be raised to Tk20,000 from Tk12,000 – Dhaka Tribune

Corporate Consultants Set Their Targets on American Universities – The Nation

Biology is having its industrial revolution – Axios

Is Adaptimmune Therapeutics PLC – ADR (ADAP) a Winner in the Biotechnology Industry? – InvestorsObserver

Covid-19 Impact On Pharmaceutical & Biotechnology Environmental Monitoring Market : Growth, Segmentation Analysis By Application And Regions To…

Is Cardiff Oncology Inc (CRDF) a Winner in the Biotechnology Industry? – InvestorsObserver

Is Adaptimmune Therapeutics PLC – ADR (ADAP) The Right Choice in Biotechnology? – InvestorsObserver

Latest Joint Venture Agreements Announced in the Pharmaceutical, Biotechnology and Diagnostic, 2020 – Virtual-Strategy Magazine

SQZ Biotech Strengthens Board of Directors and Appoints New Chief Business Officer – BioSpace

Is Aileron Therapeutics Inc (ALRN) Stock Near the Top of the Biotechnology Industry? – InvestorsObserver

Stem Cells in Regenerative Medicine: The Next Frontier in Biotechnology – The Think Curiouser

Global Agricultural Biotechnology Market Size, Market Research and Industry Forecast Report, 2025 (Includes Business Impact of COVID-19) – Eurowire

Top Insights on the Separation Systems for Commercial Biotechnology Market Leading Key Players – TechnoWeekly

Industrial Biotechnology Market 2019 By Business Opportunity, Innovations, Applications, Upcoming-Trends, Growth-Analysis, Demand-Insight,…

Virus Purification Kits Market: Consistent Expansion of Biopharmaceutical and Biotechnology Industries Boosts the Global Market – Eurowire